MXCT
MXCT’s latest rating updates from top analysts.
MaxCyte Inc’s recent filing unveils that its Director Hemrajani Rekha unloaded Company’s shares for reported $22378.0 on Jun 25 ’25. ...
Monitoring MaxCyte Inc (MXCT) after recent insider movements
MaxCyte Inc’s filing revealed that its Director Hemrajani Rekha unloaded Company’s shares for reported $22378.0 on Jun 25 ’25. In ...
Insider Selling: Hemrajani Rekha, MaxCyte Inc [MXCT] Director divested 10,684 shares
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. MaxCyte Inc ...
MaxCyte Inc (MXCT) rating downgrades by BTIG Research
MaxCyte Inc’s recent filing unveils that its Director Hemrajani Rekha unloaded Company’s shares for reported $22378.0 on Jun 25 ’25. ...
BTIG Research gives a Neutral recommendation for MaxCyte Inc (MXCT)
MaxCyte Inc’s filing revealed that its Director Hemrajani Rekha unloaded Company’s shares for reported $22378.0 on Jun 25 ’25. In ...
Keeping an Eye on MaxCyte Inc (MXCT) After Insider Trading Activity
MaxCyte Inc’s filing revealed that its Director Hemrajani Rekha unloaded Company’s shares for reported $22378.0 on Jun 25 ’25. In ...
MaxCyte Inc [MXCT] Hemrajani Rekha sells 10,684 Shares for $22378.0
MaxCyte Inc’s recent filing unveils that its Director Hemrajani Rekha unloaded Company’s shares for reported $22378.0 on Jun 25 ’25. ...
MaxCyte Inc (MXCT) rating downgrades by BTIG Research
MaxCyte Inc’s recent filing unveils that its Director Hemrajani Rekha unloaded Company’s shares for reported $22378.0 on Jun 25 ’25. ...
